A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19
Clinical trial NCT04733833 · COMPLETED
Trial details
- NCT number
- NCT04733833
- Sponsor
- Vascular Biogenics Ltd. operating as VBL Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-26
- Primary completion
- 2022-10-25
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.